Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-06-04 2020-06-04
Drug Identification Number 02299232 02299232
Brand name TEVA-FLUVASTATIN TEVA-FLUVASTATIN
Common or Proper name TEVA-FLUVASTATIN 40MG CAPS TEVA-FLUVASTATIN 40MG CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients FLUVASTATIN FLUVASTATIN
Strength(s) 40MG 40MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-20 2020-05-20
Estimated end date 2020-07-31 2020-07-31
Actual end date 2020-06-03 2020-06-03
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments